NADAMA

Suit Filed in Child’s Chelation Death

The parents of a 5-year-old autistic child who was killed by chelation therapy are suing Roy Kerry, M.D., ApothéCure (a compounding pharmacy), and several other associated individuals and companies. The suit seeks punitive damages as well as damages for wrongful death and lack of informed consent. Kerry is also facing disciplinary action by the Pennsylvania Board of Medicine. IN THE COURT OF COMMON PLEAS OF MERCER COUNTY, PENNSYLVANIA CIVIL DIVISION RUFAI NADAMA and MARWA NADAMA, Individually and on behalf of the estate of their minor son, ABUBAKAR TARIQ NADAMA and also on behalf of their minor daughter, HAUWAU NADAMA, Plaintiffs, vs. ROY E. KERRY, M.D., MARK LEWIS, M.D., ADVANCED INTEGRATIVE MEDICINE CENTER, INC., and, APOTHÉCURE, INC., APOTHÉCURE PHARMACY, APOTHÉCURE INJECTABLES, INC., SPECTRAPHARM, INC., LOBOTEJAS LABORATORIES, …